Introduction: Despite the considerable prevalence of cognitive impairment in substance-
using populations, there has been little investigation of the utility of cognitive screening …

To date, there has not been a time-efficient and resource-conscious way to identify cognitive
impairment in patients with substance use disorders (SUDs). In this study, we assessed the …

Objective: The current study assessed the criterion validity of the Montreal Cognitive
Assessment (MoCA) as a short cognitive screen for use in addiction health care. Method …

BACKGROUND: Substance abuse is associated with cognitive impairment. Participation in
clinical addiction research can be cognitively demanding. Screening tools can identify …

Objectives: Cognitive impairment is common in individuals with substance use disorders
(SUDs), yet no evidence-based guidelines exist regarding the most appropriate screening …

In this editorial we comment on the article by Cahn-Hidalgo D published in a recent issue of
the World Journal of Psychiatry 2020; 10 (1); 1-11. We focus on the importance of utilizing …

In this investigation, the authors examined the classification accuracy of the
Neuropsychological Assessment Battery-Screening Module (NAB-SM; RA Stern & T. White …

Chronic use of mind altering substances can lead to a wide variety of neuropsychological
deficits, affecting the domains of attention, learning, memory, reasoning. Executive functions …

AIM To explore the agreement between the mini-mental state examination (MMSE) and
montreal cognitive assessment (MoCA) within community dwelling older patients attending …

Abstract The American Medical Association Current Procedural Panel developed a new
billing code making behavioral health screening a reimbursable healthcare service. The use …